Nuclear oncology company Telix Pharmaceuticals (ASX:TLX) says the first two patients with advanced lung or ovarian cancer have been dosed … Read More
The post First patients dosed in trial of Telix’s cancer imaging therapy appeared first on Stockhead.
Barry Stroman was a reporter for Zerg Watch, before becoming the lead editor. Barry has previously worked for Wired, MacWorld, PCWorld, and VentureBeat covering countless stories concerning all things related to tech and science. Barry studied at NYU.